These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
446 related articles for article (PubMed ID: 21743136)
1. Neuroprotective action of lithium in disorders of the central nervous system. Chiu CT; Chuang DM Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Jun; 36(6):461-76. PubMed ID: 21743136 [TBL] [Abstract][Full Text] [Related]
2. Molecular actions and therapeutic potential of lithium in preclinical and clinical studies of CNS disorders. Chiu CT; Chuang DM Pharmacol Ther; 2010 Nov; 128(2):281-304. PubMed ID: 20705090 [TBL] [Abstract][Full Text] [Related]
4. Neuroprotective and neurotrophic actions of the mood stabilizer lithium: can it be used to treat neurodegenerative diseases? Chuang DM Crit Rev Neurobiol; 2004; 16(1-2):83-90. PubMed ID: 15581403 [TBL] [Abstract][Full Text] [Related]
5. Is There Justification to Treat Neurodegenerative Disorders by Repurposing Drugs? The Case of Alzheimer's Disease, Lithium, and Autophagy. Damri O; Shemesh N; Agam G Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33375448 [TBL] [Abstract][Full Text] [Related]
6. Neuroprotective effects of lithium: implications for the treatment of Alzheimer's disease and related neurodegenerative disorders. Forlenza OV; De-Paula VJ; Diniz BS ACS Chem Neurosci; 2014 Jun; 5(6):443-50. PubMed ID: 24766396 [TBL] [Abstract][Full Text] [Related]
7. Glycogen synthase kinase-3 in neurodegeneration and neuroprotection: lessons from lithium. Aghdam SY; Barger SW Curr Alzheimer Res; 2007 Feb; 4(1):21-31. PubMed ID: 17316163 [TBL] [Abstract][Full Text] [Related]
8. [A systematic analysis of neurobiological roles of lithium]. Gogoleva IV; Gromova OA; Torshin IY; Grishina TR; Pronin AV Zh Nevrol Psikhiatr Im S S Korsakova; 2022; 122(11):17-23. PubMed ID: 36440772 [TBL] [Abstract][Full Text] [Related]
10. An Overview of the Neurotrophic and Neuroprotective Properties of the Psychoactive Drug Lithium as an Autophagy Modulator in Neurodegenerative Conditions. Singh A; Arora S; Chavan M; Shahbaz S; Jabeen H Cureus; 2023 Aug; 15(8):e44051. PubMed ID: 37746513 [TBL] [Abstract][Full Text] [Related]
11. A new avenue for lithium: intervention in traumatic brain injury. Leeds PR; Yu F; Wang Z; Chiu CT; Zhang Y; Leng Y; Linares GR; Chuang DM ACS Chem Neurosci; 2014 Jun; 5(6):422-33. PubMed ID: 24697257 [TBL] [Abstract][Full Text] [Related]
12. Neuroprotective effects of lithium: what are the implications in humans with neurodegenerative disorders? Morlet É; Hozer F; Costemale-Lacoste JF Geriatr Psychol Neuropsychiatr Vieil; 2018 Mar; 16(1):78-86. PubMed ID: 29400298 [TBL] [Abstract][Full Text] [Related]
13. Lithium-mediated protection against ethanol neurotoxicity. Luo J Front Neurosci; 2010; 4():41. PubMed ID: 20661453 [TBL] [Abstract][Full Text] [Related]
14. Lithium up-regulates the cytoprotective protein Bcl-2 in the CNS in vivo: a role for neurotrophic and neuroprotective effects in manic depressive illness. Manji HK; Moore GJ; Chen G J Clin Psychiatry; 2000; 61 Suppl 9():82-96. PubMed ID: 10826666 [TBL] [Abstract][Full Text] [Related]
15. Lithium and disease modification: A systematic review and meta-analysis in Alzheimer's and Parkinson's disease. Singulani MP; Ferreira AFF; Figueroa PS; Cuyul-Vásquez I; Talib LL; Britto LR; Forlenza OV Ageing Res Rev; 2024 Mar; 95():102231. PubMed ID: 38364914 [TBL] [Abstract][Full Text] [Related]
16. Molecular Mechanisms of Lithium Action: Switching the Light on Multiple Targets for Dementia Using Animal Models. Kerr F; Bjedov I; Sofola-Adesakin O Front Mol Neurosci; 2018; 11():297. PubMed ID: 30210290 [TBL] [Abstract][Full Text] [Related]
18. [Neurotrophic effects of lithium stimulate the reduction of ischemic and neurodegenerative brain damage]. Pronin AV; Gogoleva IV; Torshin IY; Gromovа OA Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(2):99-108. PubMed ID: 27166488 [TBL] [Abstract][Full Text] [Related]
19. Latrepirdine: molecular mechanisms underlying potential therapeutic roles in Alzheimer's and other neurodegenerative diseases. Bharadwaj PR; Bates KA; Porter T; Teimouri E; Perry G; Steele JW; Gandy S; Groth D; Martins RN; Verdile G Transl Psychiatry; 2013 Dec; 3(12):e332. PubMed ID: 24301650 [TBL] [Abstract][Full Text] [Related]
20. High lithium levels in tobacco may account for reduced incidences of both Parkinson's disease and melanoma in smokers through enhanced β-catenin-mediated activity. Guttuso T Med Hypotheses; 2019 Oct; 131():109302. PubMed ID: 31443765 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]